RIGL - Rigel Pharmaceuticals GAAP EPS of $0.80 beats by $0.18, revenue of $57.6M in-line
2025-03-04 16:03:27 ET
More on Rigel Pharmaceuticals
- Rigel Pharmaceuticals: Realizing The Promise Of Its Acquired Pipeline Agents
- Rigel Pharmaceuticals sets 2025 sales outlook above estimates
- Seeking Alpha’s Quant Rating on Rigel Pharmaceuticals
- Historical earnings data for Rigel Pharmaceuticals
- Financial information for Rigel Pharmaceuticals